BJERKHOLT ERIC — SEC insider filings

SEC reporting owner CIK 1197350. 61 insider filings on record with FilingPulse; latest filed 2026-09-15.

Transaction summary — filings shown

Covers the 50 most recent of 61 filings on record, filed 2022-02-14 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mirum Pharmaceuticals, Inc. (MIRM)CHIEF FINANCIAL OFFICER193 legs · 14,000 sh · $397,69214 legs · 53,283 sh · $4,290,12529
CHINOOK THERAPEUTICS, INC. (KDNY)Chief Financial Officer5—4 legs · 10,413 sh · $231,71420
CERUS CORP (CERS)Director103 legs · 25,000 sh · $43,3512 legs · 40,454 sh · $88,8806
CalciMedica, Inc. (CALC)Director99 legs · 2,255 sh · $6,723—7
Surrozen, Inc./DE (SRZN)Director4——4
Metagenomi Therapeutics, Inc. (MGX)Director3——3

Insider filings — BJERKHOLT ERIC

FiledFormIssuerReported transactionsSource
2026-09-154Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 18,333 · Sale (S): 9,943 @ $98.37 · Option exercise (M): 18,333 (derivative) @ $0EDGAR
2026-08-124Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 6,001 @ $99.90EDGAR
2026-07-084Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 3,124 @ $121.67 · Sale (S): 1,048 @ $122.43 · Sale (S): 528 @ $123.84 · Sale (S): 300 @ $124.94EDGAR
2026-06-114CERUS CORP (CERS)Sale (S): 20,454 @ $2.60EDGAR
2026-06-114Metagenomi Therapeutics, Inc. (MGX)Grant/award (A): 21,000 (derivative) @ $0EDGAR
2026-06-094Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 2,258 @ $92.84 · Sale (S): 1,175 @ $93.95 · Sale (S): 1,567 @ $95.12 · Option exercise (M): 2,393 @ $26.49 · Option exercise (M): 2,393 (derivative) @ $0EDGAR
2026-06-024CERUS CORP (CERS)Grant/award (A): 60,000 @ $0EDGAR
2026-05-144Surrozen, Inc./DE (SRZN)Grant/award (A): 5,550 (derivative) @ $0EDGAR
2026-03-174Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 13,334 · Sale (S): 7,287 @ $91.98 · Option exercise (M): 13,334 (derivative) @ $0EDGAR
2026-01-304Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 18,140 (derivative) @ $0 · Grant/award (A): 11,760 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2026-01-274Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 2,667 · Sale (S): 1,053 @ $96.19 · Option exercise (M): 2,667 (derivative) @ $0EDGAR
2026-01-234Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 3,334 · Sale (S): 1,421 @ $93.33 · Option exercise (M): 3,334 (derivative) @ $0EDGAR
2025-09-124Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 18,333 · Sale (S): 9,578 @ $76.01 · Option exercise (M): 18,333 (derivative) @ $0EDGAR
2025-08-124Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 8,000 · Option exercise (M): 2,954 @ $26.49 · Option exercise (M): 2,954 (derivative) @ $0EDGAR
2025-06-124Metagenomi, Inc. (MGX)Grant/award (A): 8,572 (derivative) @ $0EDGAR
2025-06-044CERUS CORP (CERS)Grant/award (A): 60,000 @ $0EDGAR
2025-05-154Surrozen, Inc./DE (SRZN)Grant/award (A): 1,333 (derivative) @ $0EDGAR
2025-02-054Metagenomi, Inc. (MGX)Grant/award (A): 42,000 (derivative) @ $0EDGAR
2025-01-274Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 2,667 · Option exercise (M): 2,667 (derivative) @ $0EDGAR
2025-01-234Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2024-12-164CERUS CORP (CERS)Sale (S): 20,000 @ $1.78EDGAR
2024-11-144Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 475 @ $21.05EDGAR
2024-09-124Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 18,334 · Option exercise (M): 18,334 (derivative) @ $0EDGAR
2024-08-284CalciMedica, Inc. (CALC)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2024-06-064CERUS CORP (CERS)Grant/award (A): 40,000 @ $5EDGAR
2024-06-064Surrozen, Inc./DE (SRZN)Grant/award (A): 1,333 (derivative) @ $0EDGAR
2024-05-164Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 470 @ $21.05EDGAR
2024-04-224CalciMedica, Inc. (CALC)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2024-03-274Mirum Pharmaceuticals, Inc. (MIRM)Purchase (P): 2,000 @ $24.80EDGAR
2024-03-184Mirum Pharmaceuticals, Inc. (MIRM)Purchase (P): 2,000 @ $25.80EDGAR
2024-01-254Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 32,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0EDGAR
2023-12-134CERUS CORP (CERS)Purchase (P): 10,000 @ $1.62EDGAR
2023-09-124Mirum Pharmaceuticals, Inc. (MIRM)Purchase (P): 10,000 @ $29.65 · Grant/award (A): 110,000 (derivative) @ $0 · Grant/award (A): 55,000 (derivative) @ $0EDGAR
2023-08-234CERUS CORP (CERS)Purchase (P): 10,000 @ $1.72EDGAR
2023-08-114CHINOOK THERAPEUTICS, INC. (KDNY)Disposition to issuer (D): 39,371 · Disposition to issuer (D): 144,787 (derivative) @ $26.02 · Disposition to issuer (D): 21,501 (derivative) @ $24.86 · Disposition to issuer (D): 88,000 (derivative) @ $27.10 · Disposition to issuer (D): 84,000 (derivative) @ $14.73 · Disposition to issuer (D): 16,415 (derivative) · +4 moreEDGAR
2023-06-284CalciMedica, Inc. (CALC)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2023-06-094CERUS CORP (CERS)Grant/award (A): 40,000 @ $5EDGAR
2023-06-014CalciMedica, Inc. (CALC)Purchase (P): 5 @ $3.25 · Purchase (P): 100 @ $4.09 · Purchase (P): 150 @ $4.20EDGAR
2023-05-244CalciMedica, Inc. (CALC)Purchase (P): 500 @ $3.27EDGAR
2023-05-234CERUS CORP (CERS)Purchase (P): 5,000 @ $2EDGAR
2023-05-224CalciMedica, Inc. (CALC)Purchase (P): 1 @ $2.65 · Purchase (P): 199 @ $2.65EDGAR
2023-05-194Surrozen, Inc./DE (SRZN)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2023-05-184CalciMedica, Inc. (CALC)Purchase (P): 800 @ $2.70 · Purchase (P): 200 @ $2.67 · Purchase (P): 300 @ $2.70EDGAR
2023-03-274CalciMedica, Inc. (GRAY)Disposition to issuer (D): 1,429 · Disposition to issuer (D): 1,429 (derivative)EDGAR
2023-02-154CHINOOK THERAPEUTICS, INC. (KDNY)Option exercise (M): 2,435 · Sale (S): 857 @ $23.75 · Option exercise (M): 2,435 (derivative) @ $0EDGAR
2023-02-024CHINOOK THERAPEUTICS, INC. (KDNY)Option exercise (M): 7,333 · Sale (S): 2,891 @ $24.68 · Option exercise (M): 7,333 (derivative) @ $0 · Grant/award (A): 84,000 (derivative) @ $0 · Grant/award (A): 21,000 (derivative) @ $0EDGAR
2022-12-024CHINOOK THERAPEUTICS, INC. (KDNY)Option exercise (M): 16,414 · Sale (S): 5,770 @ $22.29 · Option exercise (M): 16,414 (derivative) @ $0EDGAR
2022-06-034CERUS CORP (CERS)Grant/award (A): 20,454 @ $0 · Grant/award (A): 39,866 (derivative)EDGAR
2022-06-034GRAYBUG VISION, INC. (GRAY)Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-02-144CHINOOK THERAPEUTICS, INC. (KDNY)Option exercise (M): 2,434 · Sale (S): 895 @ $12.74 · Option exercise (M): 2,434 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1197350 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs